Drug recall D-1439-2014
Product
Velivet (desogestrel and ethinyl estradiol tablets - triphasic regimen), 0.1 mg/0.025 mg; 0.125 mg/0.025 mg; 0.15 mg/0.025 mg, 3 Dispensers x 28 Tablets, Barr Laboratories, Inc., Pomona, NY NDC 0555-9051-67
Reason for recall
Failed Impurities/Degradation Specifications: out of specification impurity test results.
Lots and codes
Lot 33805449A, Exp. 12/14
Recall details
- Recalling firm
- Teva Pharmaceuticals USA, North Wales, PA
- Quantity
- 5265 blister packs
- Distribution
- Nationwide
- Type
- Voluntary: Firm initiated
- Recall initiated
- June 17, 2014
- Terminated
- March 9, 2015
Related products
- Velivet – drug information
- NDC 0555-9051 Velivet Triphasic Regimen · · Teva Pharmaceuticals USA, Inc.